Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione.
Zeynep
Z
Ebcioglu
John
J
Morgan
Christina
C
Carey
David
D
Capuzzi
D000328:Adult; D008076:Cholesterol, HDL / Q000187:drug effects*; D004359:Drug Therapy, Combination; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D045162:Thiazolidinediones / Q000009:adverse effects*
D008076:Cholesterol, HDL; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione; D011345:Fenofibrate